| Tretinoin | Approved Investigational Nutraceutical | EFEMP1 | 2202 |
downregulated | Tretinoin results in decreased expression of EFEMP1 mRNA | 2p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EFEMP1 | 2202 |
upregulated | Tretinoin results in increased expression of EFEMP1 mRNA | 2p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EFEMP2 | 30008 |
upregulated | Tretinoin results in increased expression of EFEMP2 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EFHD2 | 79180 |
downregulated | Tretinoin results in decreased expression of EFHD2 mRNA | 1p36.21 | |
| Tretinoin | Approved Investigational Nutraceutical | EFNA1 | 1942 |
downregulated | Tretinoin results in decreased expression of EFNA1 mRNA | 1q22 | |
| Tretinoin | Approved Investigational Nutraceutical | EFNA4 | 1945 |
downregulated | Tretinoin results in decreased expression of EFNA4 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EFNA5 | 1946 |
downregulated | Tretinoin results in decreased expression of EFNA5 mRNA | 5q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EFNB1 | 1947 |
downregulated | Tretinoin results in decreased expression of EFNB1 mRNA | Xq13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EFNB2 | 1948 |
upregulated | Tretinoin results in increased expression of EFNB2 mRNA | 13q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EFS | 10278 |
downregulated | Tretinoin results in decreased expression of EFS mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EGF | 1950 |
upregulated | Tretinoin results in increased expression of EGF mRNA | 4q25 | |
| Tretinoin | Approved Investigational Nutraceutical | EGFLAM | 133584 |
downregulated | Tretinoin results in decreased expression of EGFLAM mRNA | 5p13.2-p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EGFR | 1956 |
downregulated | Tretinoin metabolite results in decreased expression of EGFR mRNA | 7p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EGFR | 1956 |
upregulated | Tretinoin results in increased expression of EGFR mRNA | 7p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EGLN1 | 54583 |
upregulated | Tretinoin results in increased expression of EGLN1 mRNA | 1q42.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EGR1 | 1958 |
upregulated | Tretinoin results in increased expression of EGR1 mRNA | 5q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EGR2 | 1959 |
upregulated | Tretinoin results in increased expression of EGR2 mRNA | 10q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EGR3 | 1960 |
upregulated | Tretinoin results in increased expression of EGR3 mRNA | 8p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EHBP1 | 23301 |
downregulated | Tretinoin results in decreased expression of EHBP1 mRNA | 2p15 | |
| Tretinoin | Approved Investigational Nutraceutical | EHBP1L1 | 254102 |
upregulated | Tretinoin results in increased expression of EHBP1L1 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EHD1 | 10938 |
upregulated | Tretinoin results in increased expression of EHD1 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EHD4 | 30844 |
upregulated | Tretinoin results in increased expression of EHD4 mRNA | 15q15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF1B | 10289 |
upregulated | Tretinoin results in increased expression of EIF1B mRNA | 3p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF2A | 83939 |
downregulated | Tretinoin results in decreased expression of EIF2A mRNA | 3q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EIF2S1 | 1965 |
downregulated | Tretinoin results in decreased expression of EIF2S1 mRNA | 14q23.3 | |